
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Clin. Diabetes Healthc.
Sec. Diabetes Clinical Epidemiology
Volume 6 - 2025 | doi: 10.3389/fcdhc.2025.1426120
This article is part of the Research Topic The Model of Ramadan Diurnal Intermittent Fasting: Unraveling the Health Implications - Volume 3 View all 13 articles
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
In diabetic patients intending to fast, Ramadan, risk assessment, and stratification are essential for an individualized treatment plan. The new IDF-DAR risk stratification tool (International Diabetes Federation -Diabetes and Ramadan Alliance) is becoming the primary tool. This study aims to validate this tool in the Abu Dhabi population.The assessment was done before Ramadan, followed by an evaluation of any significant outcome after Ramadan through tele-interview and an electronic medical records review. Patients were included if the attending physicians used the tool in the risk assessment of the patients within six weeks before Ramadan 1444, 2022, in the AHS healthcare center.The study included 435 patients. Half (51.7%) were in the low-risk category of the IDF-DAR risk stratification tool, 28.5% in the moderate-risk category, and 19.8% in the higher-risk category. Of the patients who fasted all of Ramadan, 81.3% and 18.7% attempted to fast. Of the sample, 14 (3.8%) were admitted at least once, and 56 (12.9%) had at least one significant event, including admission to the hospital.Using univariable logistic regression, the occurrence of adverse events was significantly associated with more days not fasted B= -0.126, p<0.001, OR=0.88 (0.839-0.927). Other risk factors identified of the occurrence of adverse events using multivariable logistic regression controlled for all variables studied in this study were; being in the low-risk category of the DAR risk assessment tool B= -1.1, OR= 0.34 (0.157-0.744), p value=0.0072, being in the frail category compared to the reference category, the robust category, B=1.54,) p value=0.018 and older age B= -0.034, OR=0.966 (0.938-0.995). There was no significant difference between moderate and high-risk categories in the occurrence of SAE. Similar determinants were identified of fasting all Ramadan using multivariable logistic regression.According to the IDF-DAR risk assessment, diabetic patients in the low-risk category had a better outcome than those in the Moderate or high-risk categories regarding significant adverse events.Another independent risk factor is if the patient is Frail, according to the FRAIL scoring.
Keywords: Diabetes Mellitus, ramadan, Fasting, adverse events, Risk Assessment
Received: 30 Apr 2024; Accepted: 17 Feb 2025.
Copyright: © 2025 Baynouna Al Ketbi, Afandi, Nagelkerke, Abdubaqi, Al Nuaimi, Al Saedi, Al Blooshi, Al Blooshi, AlAryani, Al Marzooqi, Al Khouri, Al Mansoori and Hassanein. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Latifa Mohammad Baynouna Al Ketbi, Abu Dhabi Healthcare Services, Ambulatory Healthcare Services., Al Ain, United Arab Emirates
Bachar Afandi, Tawam Hospital, Al Ain, Abu Dhabi, United Arab Emirates
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.